Key result
A rapid and selective LC-MS method was successfully developed and validated for the evaluation of amlodipine (0.1-10 ng/mL) and atorvastatin (0.2-20 ng/mL) in human plasma.
A rapid and selective LC-MS method was successfully developed and validated for the simultaneous evaluation of amlodipine and atorvastatin in human plasma.
May facilitate pharmacokinetic studies of combination therapy; leaves open clinical therapeutic monitoring pending further validation.
A rapid and selective liquid chromatography–mass spectrometry (LC–MS) method was developed for the evaluation of amlodipine and atorvastatin in human plasma. Detection of analytes was assigned by tandem mass spectrometry with electrospray ionization interface in positive ion mode was applied under the multiple-reaction monitoring mode (MRM). Analytes were extracted from plasma by simple liquid–liquid extraction technique using ethyl acetate. The reconstituted samples were chromatographed on C18 column by pumping acetonitrile–water (10 mM CH3COONH4, pH 3.0) = 70:30 (v/v) at a flow rate of 0.15 mL/min. The standard curves were assigned to be linear in the range of 0.2–20 ng/mL for atorvastatin and 0.1–10 ng/mL for amlodipine with mean correlation coefficient of ≥0.999 for each analyte. The intra-day and inter-day precision and accuracy results were well within the acceptable limits. The urbanized evaluate method was successfully applied to validation of amlodipine and atorvastatin in human plasma.
No takes yet. Share an insight, caveat, or question.
Danafar et al. (2016) studied this question. Liquid chromatography-mass spectrometry (LC-MS) method was evaluated on Method validation (linearity, precision, and accuracy). A rapid and selective LC-MS method was successfully developed and validated for the evaluation of amlodipine (0.1-10 ng/mL) and atorvastatin (0.2-20 ng/mL) in human plasma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: